💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @TranscriptDaily | 6 |
| @Steve_382 | 6 |
| @stocknewstimes | 6 |
| @otcdynamics | 4 |
| @TheMarketsDaily | 4 |
Recent Tweets for ALNY
 |
@BACScoreChanges #AlnylamPharmaceuticals $ALNY BidaskScore is Lowered to Sold https://t.co/1HUrqsgwbY October 22nd 2020, 8:10pm |
 |
@otcdynamics $ALNY Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results https://t.co/Lexf53gg0h October 22nd 2020, 4:10pm |
 |
@FlashAlert_me $ALNY [15s. delayed]: Issued Press Release on October 22, 16:00:00: Alnylam to Webcast Conference Call Discussing T… https://t.co/lGFhiFNtGA October 22nd 2020, 4:10pm |
 |
@stock_titan $ALNY Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results https://t.co/Kx17rGA5FH October 22nd 2020, 4:10pm |
 |
@Briefingcom $ALNY: Alnylam Pharma announced results from the 6-month primary analysis of the ILLUMINATE-B Phase 3 pediatric... https://t.co/NBRitfS0l4 October 22nd 2020, 12:10pm |
 |
@newsfilterio Alnylam's lumasiran shows treatment benefit in rare kidney disorder $ALNY https://t.co/x1A7jKnG9C October 22nd 2020, 10:10am |
 |
@HealthcareBeat Alnylam's lumasiran shows treatment benefit in rare kidney disorder $ALNY https://t.co/Eardo6HRDH October 22nd 2020, 10:10am |
 |
@MarketCurrents $ALNY - Alnylam's lumasiran shows treatment benefit in rare kidney disorder https://t.co/86c3klujaD October 22nd 2020, 10:10am |
 |
@sbwcws Alnylam: Lumasiran showed 72% reduction in urinary oxalate in Phase 3 study $ALNY October 22nd 2020, 10:10am |
|
@otcdynamics $ALNY Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxa… https://t.co/Am68OFikUv October 22nd 2020, 10:10am |
|
@FlashAlert_me $ALNY [15s. delayed]: Issued Press Release on October 22, 10:00:00: Alnylam Presents Positive Results from ILLUMINA… https://t.co/vrXTrD2XZj October 22nd 2020, 10:10am |
|
@stock_titan $ALNY Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxa… https://t.co/eObPauD2cZ October 22nd 2020, 10:10am |
 |
@WatchlistN Analysts Expect Alnylam Pharmaceuticals, Inc. $ALNY Will Announce Quarterly Sales of $117.53 Million https://t.co/pcQiu9dxTM October 22nd 2020, 1:10am |
 |
@KillerStockCall Potential Near Future Catalysts $ALNY Drug: ALN-GO1 Date: 22 Oct 2020 Full Results Phase 3 $OMER Drug: OMS721 Da… https://t.co/BWok44mHrT October 21st 2020, 9:10pm |
 |
@Steve_382 $ALNY Topline results from the ILLUMINATE-B pediatric study were reported in September; results from the primary a… https://t.co/KxuxbLeL11 October 21st 2020, 12:10pm |
 |
@stocknewstimes FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/kkddAgYSIG October 21st 2020, 11:10am |
 |
@TranscriptDaily FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/YzM3G4ojj2 October 21st 2020, 11:10am |
 |
@TheMarketsDaily FY2020 EPS Estimates for Alnylam Pharmaceuticals, Inc. Cut by Analyst $ALNY https://t.co/1PnW620alF October 21st 2020, 11:10am |
|
@TranscriptDaily FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/RcH6B7e8y3 October 21st 2020, 11:10am |
 |
@EnterpriseLeade FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/YGlOSikB5Q October 21st 2020, 11:10am |
|
@TheMarketsDaily FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/erpy4P4AAx October 21st 2020, 11:10am |
|
@TranscriptDaily FY2020 Earnings Estimate for Alnylam Pharmaceuticals, Inc. Issued By Jefferies Financial Group $ALNY https://t.co/Zs9CddBdao October 21st 2020, 11:10am |
|
@stocknewstimes FY2020 Earnings Forecast for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/16T3Pezoi9 October 21st 2020, 11:10am |
|
@WatchlistN Jefferies Financial Group Research Analysts Reduce Earnings Estimates for Alnylam Pharmaceuticals, Inc. $ALNY https://t.co/kWxinnDYMt October 21st 2020, 3:10am |
 |
@AmericanBanking Brokerages Expect Alnylam Pharmaceuticals, Inc. $ALNY to Post -$1.75 Earnings Per Share https://t.co/YpxvfuhRhU #stocks October 20th 2020, 9:10pm |
 |
@BlueBioNow $ALNY I'd like to make an exit, just not now -3.27 % change recently https://t.co/aSQcF6S6Ua October 20th 2020, 9:10pm |
|
@Steve_382 @DewDiligence That $ALNY $VIR chat was very interesting. Over my head scientifically, but the cooperation seems very sincere. October 20th 2020, 1:10pm |
 |
@dispatchtribune FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/wv135MSAFh October 20th 2020, 6:10am |
|
@AmericanBanking FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/uV2N0GxiHA #stocks October 20th 2020, 6:10am |
 |
@ZolmaxNews FY2024 Earnings Estimate for Alnylam Pharmaceuticals, Inc. $ALNY Issued By Jefferies Financial Group https://t.co/RXLFoeodML October 20th 2020, 6:10am |
|
@BlueBioNow $ALNY Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. -3.56 % change recently https://t.co/aSQcF6S6Ua October 20th 2020, 6:10am |
 |
@thegreenisback Is Ionis Pharmaceuticals a Buy? @themotleyfool #stocks $IONS $ALNY https://t.co/06SwKFYnfI October 19th 2020, 2:10pm |
|
@Steve_382 $ALNY $VIR I don't expect much from this, but tomorrow at 12:30 ET. Both stocks hammered today in advance. Vir and… https://t.co/dahw23xPXt October 19th 2020, 2:10pm |
 |
@AlertTrade RT @AlertTrade: REVERSALtoDOWN: $ALNY Alnylam Pharmaceuticals, Inc https://t.co/wedZS50nBI ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x October 19th 2020, 1:10pm |
|
@AlertTrade REVERSALtoDOWN: $ALNY Alnylam Pharmaceuticals, Inc https://t.co/wedZS50nBI ? ? TradeIdeas via ? https://t.co/ZgCyz4rX3x October 19th 2020, 12:10pm |
 |
@OTSociety RT @RNAiAnalyst: $ALNY not only 1, but 2 European CHMP positive opinions on 1 day. In addition to $NVS-partnered LDLc-lowering PCSK9 RNAi,… October 19th 2020, 7:10am |
|
@TranscriptDaily Bank of America Cuts Alnylam Pharmaceuticals $ALNY Price Target to $157.00 https://t.co/0kc8u6uDQO October 19th 2020, 3:10am |
|
@TheMarketsDaily Alnylam Pharmaceuticals $ALNY PT Lowered to $157.00 at Bank of America https://t.co/HoT1JD7sOO October 19th 2020, 3:10am |
 |
@wh3atth1nz $ALNY reclaimed the 50 day SMA and forming a low handle type consolidation. https://t.co/xvRDB3MmCP October 18th 2020, 5:10pm |
|
@thegreenisback The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference $ABT $ALNY… https://t.co/v4sHExaCUj October 18th 2020, 1:10pm |
 |
@RipShowStocks $ALNY Consolidating before its next move higher. Levels, resistance/support to trade: https://t.co/2lPePBh04u October 18th 2020, 1:10pm |
 |
@Gambiste1 RT @WhyteStocks: Just In: $ALNY Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus? In 1962, the Nob $ALNY http… October 18th 2020, 9:10am |
 |
@WhyteStocks Just In: $ALNY Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus? In 1962, the Nob… https://t.co/MQKfQ2Qxwo October 18th 2020, 7:10am |
|
@dispatchtribune Bank of America Trims Alnylam Pharmaceuticals $ALNY Target Price to $157.00 https://t.co/M7eHjyerDC October 18th 2020, 4:10am |
|
@ZolmaxNews Bank of America Trims Alnylam Pharmaceuticals $ALNY Target Price to $157.00 https://t.co/rmsb88vyYv October 18th 2020, 4:10am |
 |
@Amarshall7M @RNAiAnalyst I was a bit surprised this news was as priced in as it appears to be. O patrol is clearly a show me story. $ALNY October 17th 2020, 10:10am |
|
@HealthcareBeat European advisory group backs Alnylam's lumasiran in rare inherited liver disorder $ALNY https://t.co/8AYVF9Wpze October 17th 2020, 6:10am |
 |
@RNAiAnalyst $ALNY not only 1, but 2 European CHMP positive opinions on 1 day. In addition to $NVS-partnered LDLc-lowering PCSK9… https://t.co/vqu3GZl3Qz October 17th 2020, 4:10am |
 |
@equity_newswire $ALNY Alnylam Receives Positive CHMP Opinion for OXLUMO™ (lumasiran) for the Treatment of Primary Hyperoxaluria Typ… https://t.co/lzKAwKMBZR October 16th 2020, 6:10pm |
 |
@MaisaCorp $ALNY said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended th… https://t.co/HmbhFeBEyy October 16th 2020, 3:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities